Comprehensive analysis identifies Myc and Skp2's role in p27 degradation in Ewing sarcoma, suggesting new treatment pathways.
This mechanism was identified through a comprehensive expression analysis aimed at uncovering the drivers of cell cycle acceleration in Ewing sarcoma. The findings offer new insights into therapeutic strategies for this malignancy, which has seen little progress in treatment over several decades. This discovery holds the potential to transform the current landscape, as no effective molecularly targeted therapies have yet been developed.
No takes yet. Share an insight, caveat, or question.
Kubota et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: